We recommend:

  1. EDs lead and are actively involved in COVID-19 clinical research. This research will include but not be limited to:
    • Biological sampling of COVID-19 patients to understand the pathophysiology of differential mortality in patient groups.
    • Clinical registries for epidemiology and prognostic prediction.
    • Clinical trials of pharmacological and non-pharmacological  prophylaxis and treatments.
    • Qualitative evaluations of individual and systems responses to a pandemic.
  2. Clinical research aligns and integrates with international efforts for harmonisation and coordination of research (such as the International Severe Acute Respiratory and Emerging Infections Consortium COVID-19 Case Record Form [Link], and the World Health Organization Research and Development Framework [Link]).
  3. The use of EMER (Emergency Medicine Events Register) to anonymously report adverse events, near misses or good saves that relate directly or indirectly to the pandemic. This might include incidents such as delayed emergency presentations due to fear of attending the hospital, issues related to mental health presentations, problems around equipment and procedures, ED streaming of patients into COVID and non-COVID areas, the use of telemedicine or issues around civility in the workplace. Themes relating to recurrent incidents during the pandemic will be analysed and communicated back to members by the ACEM EMER team.

  • Section disclaimer
  • Resources